| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 58.02M | 63.04M | 74.44M | 107.79M | 114.59M |
| Gross Profit | -8.88M | 5.47M | 7.87M | 13.84M | 17.36M |
| EBITDA | -10.84M | -10.05M | -11.06M | 2.15M | 5.09M |
| Net Income | -13.36M | -15.68M | -16.59M | -8.71M | -5.04M |
Balance Sheet | |||||
| Total Assets | 117.84M | 135.95M | 132.36M | 173.35M | 174.65M |
| Cash, Cash Equivalents and Short-Term Investments | 11.52M | 26.45M | 5.93M | 7.18M | 6.90M |
| Total Debt | 1.23M | 4.79M | 12.13M | 23.65M | 19.73M |
| Total Liabilities | 8.22M | 12.98M | 22.55M | 46.94M | 39.53M |
| Stockholders Equity | 109.61M | 122.97M | 109.81M | 126.41M | 135.12M |
Cash Flow | |||||
| Free Cash Flow | -13.02M | 1.13M | 17.81M | -3.52M | 19.76M |
| Operating Cash Flow | -12.52M | 1.29M | 20.17M | -3.48M | 20.12M |
| Investing Cash Flow | -330.00K | -108.00K | 3.72M | 17.00K | 7.52M |
| Financing Cash Flow | -2.08M | 19.34M | -25.14M | 3.75M | -26.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$284.00M | 7.57 | 11.22% | ― | 15.66% | -1.25% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | HK$309.85M | 16.35 | 4.24% | 1.30% | -4.14% | -21.15% | |
45 Neutral | HK$455.28M | -61.50 | -16.93% | ― | -18.68% | -3305.88% | |
43 Neutral | HK$138.58M | -39.56 | -7.27% | ― | -32.89% | 57.23% | |
40 Underperform | HK$91.98M | 458.76 | -65.18% | ― | ― | ― | |
40 Underperform | HK$84.75M | -1.39 | 19.01% | ― | 3.35% | 17.48% |